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INTRODUCTION
  Ischemic Colitis (IC) is the most common form of ischemic 
bowel disease. It usually presents with a sudden onset of 
abdominal pain followed by hematochezia within 24 hours.1 
  Risk factors include age >60, cardiovascular disease, diabetes, 
peripheral vascular disease, vascular surgery and drug therapy.2 
  Only a few cases of triptan associated IC have been reported.3-10 
  We report a rare case of sumatriptan induced IC as well as 
cerebrovascular accident (CVA) in the absence of cardiovascular 
disease. 
CASE PRESENTATION
  A 58-year-old Caucasian female with a past medical history of 
longstanding daily migraines presented with sudden onset of 
abdominal pain and bloody diarrhea. Patient subsequently 
developed left upper extremity weakness and paresthesia’s. 
  Patient was using sumatriptan-naproxen 10-60 mg 4 days a 
week. Patient denied recent sick contacts, fever, chills, recent 
travel, change in dietary habits, or recent antibiotic use. Patient 
was not taking oral contraceptives, was never a tobacco 
smoker, and denied illicit drug use. Patient did not have a 
history of coronary artery disease, diabetes mellitus, or 
cerebrovascular disease. 
  Computed tomography (CT) of the abdomen and pelvis showed 
rectosigmoid colitis. Flexible Sigmoidoscopy performed, 
revealing dusky appearing sigmoid colon. Biopsy of the 
descending colon consistent with IC. 
  Laboratory findings showed minimally low protein S without 
factor V Leiden mutation; however, this has low positive 
predictive value during an acute clot, hypercoagulability workup 
otherwise normal. Laboratory findings were normal and stool 
studies remained negative for infection. 
  Magnetic resonance imaging (MRI) of the brain was suggestive 
2-3 small acute infarcts in the right parietal lobe. Venous 
doppler’s of bilateral lower extremities were negative for deep 
vein thrombosis. 
  Transesophageal Echocardiogram and Transthoracic 
Echocardiogram were negative for thrombus or patent  
foramen ovale. Transcranial doppler with bubble study  
was negative. Patient was placed on a loop recorder that  
was negative for paroxysmal atrial fibrillation. 
  Patient was diagnosed with cryptogenic CVA as her inpatient 
workup was negative. 
  Sumatriptan was discontinued. 
DISCUSSION
  This report demonstrates a case of histology proven IC and 
CVA in the absence of cardiovascular disease, atrial fibrillation, 
or intermittent low flow state of the systemic circulation. 
  Our patient did not have any other known factors that would 
precipitate her IC including other prescription or illicit drugs use. 
  Considering the above, is likely that her IC and her CVA was 
caused by her long-term use of sumatriptan. 
  Triptans cause an agonist effect on the mesenteric 5-HT1B/1D 
receptors leading to vasoconstriction, reducing blood flow and 
causing IC.8 
CONCLUSION
  Risk factors for ischemic events should be considered prior to 
prescribing triptan medications
  There needs to be increased awareness of IC as a severe 
adverse event of triptan use.
